DEEPSEEK SEEKS $300M IN FIRST OUTSIDE FUNDING ROUND
AI DESK■ 2 MIN READ
FRI, APR 17, 2026■ AI-SUMMARIZED FROM 3 SOURCES ▸ TIMELINE
DeepSeek is raising outside capital for the first time, targeting at least $300 million at a valuation of $10 billion or more. The funding round aims to strengthen the Chinese AI company's position in the competitive generative AI market.
DeepSeek, the Chinese artificial intelligence startup, is in talks to secure its first external investment, according to sources cited by The Information. The company seeks a minimum of $300 million in this funding round and is targeting a valuation of at least $10 billion.
The capital injection comes as DeepSeek works to bolster its financial resources for the intensifying competition in AI development. Building and maintaining large language models requires significant computational infrastructure and ongoing research investment, making substantial funding crucial for scaling operations.
DeepSeek has gained attention in recent months for its AI models and research contributions to the generative AI field. The startup's move to raise institutional capital marks a shift from its previous funding model and suggests plans for accelerated growth and expanded capabilities.
The valuation target of $10 billion would place DeepSeek among the higher-valued AI startups globally, reflecting investor confidence in the space and the company's technical capabilities. The timing of the funding round aligns with broader industry trends of increased investment in AI infrastructure and model development.
As the AI landscape becomes increasingly competitive, with major players like OpenAI, Anthropic, and others competing for talent and resources, securing substantial funding has become essential for companies seeking to maintain technological relevance and market position. The capital will likely support research acceleration, talent acquisition, and infrastructure expansion.
No confirmed investors or additional details about the funding timeline have been disclosed at this stage. The Information's sources indicate these are ongoing talks, meaning terms and investor commitments remain fluid.
■ MORE FROM THE STARTUPS DESK
Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.
18H AGO— AI Desk
Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.
18H AGO— AI Desk
Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.
YESTERDAY— AI Desk
H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.
YESTERDAY— Industry Desk